Evidence map›Paper›PMID 42724133›Full record

ArticleCirculation reports2026

Development and External Validation of a Machine Learning-Based Bleeding Risk Score for Patients Undergoing Percutaneous Coronary Intervention.

Tatsuya Tokai, Masanobu Ishii, So Ikebe, Taishi Nakamura, Kenichi Tsujita, Naoyuki Akashi, Hideo Fujita, Yasuhiro Nakano, Tetsuya Matoba, Takahide Kohro and 15 more

Abstract read
In one paragraph

Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Tatsuya TokaiDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
Masanobu IshiiDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
So IkebeDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
Taishi NakamuraDepartment of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
Naoyuki AkashiDivision of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University Saitama Japan.
Hideo FujitaDivision of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University Saitama Japan.
Yasuhiro NakanoDepartment of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences Fukuoka Japan.
Tetsuya MatobaDepartment of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences Fukuoka Japan.
Takahide KohroDepartment of Clinical Informatics, Jichi Medical University School of Medicine Tochigi Japan.
Yusuke ObaDivision of Cardiovascular Medicine, Jichi Medical University School of Medicine Tochigi Japan.
Hisaki MakimotoDivision of Cardiovascular Medicine, Jichi Medical University School of Medicine Tochigi Japan.
Tomoyuki KabutoyaDivision of Cardiovascular Medicine, Jichi Medical University School of Medicine Tochigi Japan.
Kazuomi KarioDivision of Cardiovascular Medicine, Jichi Medical University School of Medicine Tochigi Japan.
Yasushi ImaiDivision of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University Tochigi Japan.
Satoshi KoderaDepartment of Cardiovascular Medicine, the University of Tokyo Hospital Tokyo Japan.
Arihiro KiyosueDepartment of Cardiovascular Medicine, the University of Tokyo Hospital Tokyo Japan.
Yoshiko MizunoDepartment of Cardiovascular Medicine, the University of Tokyo Hospital Tokyo Japan.
Kotaro NochiokaDivision of Cardiovascular Medicine, Tohoku University Hospital Miyagi Japan.
Masaharu NakayamaDepartment of Medical Informatics, Tohoku University Graduate School of Medicine Miyagi Japan.
Takamasa IwaiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center Osaka Japan.
Yoshihiro MiyamotoOpen Innovation Center, National Cerebral and Cardiovascular Center Osaka Japan.
Hisahiko SatoPrecision Inc. Tokyo Japan.
Ryozo NagaiJichi Medical University School of Medicine Tochigi Japan.
CLIDAS Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Conventional bleeding risk scores after percutaneous coronary intervention (PCI) have limited discrimination and external validation, so we developed and validated a machine learning (ML)-based bleeding risk score using real-world data. Methods and Results: The primary outcome was major bleeding. In the Clinical Deep Data Accumulation System (CLIDAS) cohort, bleeding events occurring >30 days after PCI were identified by chart review and classified as moderate or severe bleeding by the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries criteria. In the Health, Clinic, and Education Information Evaluation Institute (HCEI) cohort, major bleeding was identified using ICD-10 codes and Diagnosis Procedure Combination (DPC) data. We analyzed 2,502 acute coronary syndrome patients undergoing PCI from CLIDAS and externally validated the model in 10,928 patients from HCEI. A total of 5 ML algorithms were trained. Key predictors were age, body mass index, Btype natriuretic peptide, and hemoglobin. Logistic regression demonstrated the best performance (area under the curve [AUC] 0.748) and was used to derive the CLIDAS bleeding risk score. The CLIDAS score outperformed the binary J-HBR (AUC 0.74 vs. 0.63, P=0.007) and binary ARC-HBR (AUC 0.74 vs. 0.62, P=0.011), but in external validation the CLIDAS score demonstrated limited discrimination (AUC 0.64), lower than continuous conventional scores. Conclusions: Our novel ML-based bleeding risk score showed better discrimination than conventional binary classifications in the derivation/internal validation, but external performance was limited.

Indexed as

Clinical Deep Data Accumulation System (CLIDAS)High bleeding riskMachine learningPercutaneous coronary intervention

Identifiers

PMID42724133
PMCPMC13558253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.